References: Australian Institute of Health and Welfare (AIHW). Cancer in Australia 2019. Cancer series no. 119. Cat. No. CAN 123. Canberra: AIHW.
Amin MB, Edge SB, Greene FL (eds). AJCC Cancer Staging Manual, 8th edn. New York: Springer, 2017.
Faries MB, Thompson JF, Cochran AJ et al. Completion dissection or observation for sentinel-node metastasis in melanoma. New Engl. J. Med. 2017; 376: 2211-22.
Leiter U, Stadler R, Mauch C et al. Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol. 2016; 17: 757-67.
Gershenwald JE, Scolyer RA, Hess KR et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J. Clin. 2017;67:472-92.
Long GV, Hauschild A, Santinami M et al. Adjuvant dabrafenib plus trametinib in stage III BRAF-mutated melanoma. New Engl. J. Med. 2017; 377: 1813-23.
Weber J, Mandala M, Vecchio M et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. New Engl. J. Med. 2017; 377: 1824-35.
Eggermont A, Blank CU, Mandala M et al. Adjuvant pembrolizumab versus placebo in resected stage III melanoma. New Engl. J. Med. 2018; 378: 1789-801.
Schuchter LM. Adjuvant melanoma therapy - head-spinning progress. New Engl. J. Med. 2017; 377: 1888-1890.
Cancer Council Australia Melanoma Guidelines Working Party. Clinical practice guidelines for the diagnosis and management of melanoma. Sydney: Cancer Council Australia. Available from: https://wiki.cancer.org.au/australia/Guidelines:Melanoma.
Watts CG, Madronio CM, Morton RL et al. Diagnosis and clinical management of melanoma patients at higher risk of a new primary melanoma: A population-based study in New South Wales, Australia. Australas. J. Dermatol. 2017; 58: 278-85.
McGregor JM, Sasieni P. Sentinel node biopsy in cutaneous melanoma: time for consensus to better inform patient choice. Br J Dermatol. 2015; 172: 552-4.
Zagarella S. Sentinel lymph node biopsy still provides no benefits for patients with melanoma. Am. J. Dermatopathol. 2020; 1: 481-483.
Sladden M, Zagarella S, Popescu C et al. The sentinel node biopsy has not come of age. Br. J. Dermatology. 2019; 182: 518.
Bigby M, Zagarella S, Sladden M et al. Time to reconsider the role of sentinel lymph node biopsy in melanoma. J. Am. Acad. Dermatol. 2018; 80: 1168-1171.
Smithers MB, Hughes MB, Beesley VL et al. Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia. J. Surg. Oncol. 2015; 112: 359-65.
Varey AH, Madronio CM, Cust AE et al. Poor adherence to national clinical management guidelines: a population-based, cross-sectional study of the surgical management of melanoma in New South Wales, Australia. Ann. Surg. Oncol. 2017; 24(8): 2080-8.
Silva E. Adjunct primer for the use of national comprehensive cancer network guidelines for the surgical management of cutaneous malignant melanoma patients. World J. Surg. Oncol. 2012; 10: 54.
Grange F, Vitry F, Granel-Brocard F et al. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch. Dermatol. 2008; 144: 629-36.
Sharouni M-AE, Witkamp AJ, Sigurdsson V et al. Trends in sentinel lymph node biopsy enactment for cutaneous melanoma. Ann. Surg. Oncol. 2019; 26: 1494-502.
Watts C, Smith AL, Robinson S et al. Australian general practitioners’ attitudes and knowledge of sentinel lymph node biopsy in melanoma management. Aust. J. Gen. Pract. 2020; 49: 355-62.
Sandelowski M. Combining qualitative and quantitative sampling, data collection, and analysis techniques in mixed-method studies. Res. Nurs. Health. 2000; 23: 246-55.
Australian Bureau of Statistics (ABS)Socio-Economic Indexes for Areas (SEIFA): The Index for Relative Socio-Economic Advantage and Disadvantage. Canberra: ABS. 2018.
McNutt L-A, Wu C, Xue X et al. Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am. J. Epidemiol. 2003; 157: 940-3.
Braun V, Clarke V. Reflecting on reflexive thematic analysis. Qual. Res. Sport Exerc. Heal. 2019; 11: 1-9.
Braun V, Clarke V. Using thematic analysis in psychology. Qual. Res. Psychol. 2006; 3: 77-101.
Flottorp SA, Oxman AD, Krause J et al. A checklist for identifying determinants of practice: A systematic review and synthesis of frameworks and taxonomies of factors that prevent or enable improvements in healthcare professional practice. Implement. Sci. 2013; 8: 35.
Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int. J. Qual. Health Care 2007; 19: 349-57.
von Elm E, Altman DG, Egger M et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int. J. Surg. 2014; 12: 1495-9.
Morton DL, Thompson JF, Cochran AJ et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. New Engl. J. Med. 2014; 370: 599-609.
Cabana MD, Rand CS, Powe NR et al. Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 1999; 282: 1458-65.
Grol R, Wensing M. What drives change? Barriers to and incentives for achieving evidence-based practice. Medical J. Australia 2004; 180(6 Suppl): S57-60.
Streiner DL, Norman GR. Correction for multiple testing is there a resolution? Chest 2011; 140: 16-8.
Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-6.
Moran-Ellis J, Alexander VD, Cronin A et al. Triangulation and integration: processes, claims and implications. Qual. Res. 2006; 6: 45-59.
Willson ML, Vernooij RWM, Gagliardi AR et al. Questionnaires used to assess barriers of clinical guideline use among physicians are not comprehensive, reliable, or valid: a scoping review. J. Clin. Epidemiol. 2017;86:25-38.
Mar V, Kelly J, Soyer HP et al. Sentinel node biopsy in 2020: a guide for Australian dermatologists [Internet]. Sydney, Australia: Australasian College of Dermatologists, 2020. Available from: https://www.dermcoll.edu.au/wp-content/uploads/2020/01/ACD-Guide-for-Sentinel-Node-Biopsy-in-2020-Jan-2020.pdf.
Australian Bureau of Statistics (ABS). The Australian Statistical Geography Standard (ASGS) remoteness structure. ABS. 2018.
No Comments.